However, in breast cancer, some high-grade malignant human breast cancer cell lines (such as MDA-MB-231) express high levels of BTN3A3, while low-grade malignant cell lines (such as MCF-7) express lower levels of BTN3A3 63. This evidence concerns the gene BTN3A3 and breast carcinoma.